Morpheus BioLabs is a Contract Research Organization (CRO) that is specialized in providing biomedical research with an emphasis in immunology, auto-immunity, inflammation, microbiology, molecular biology infection, microbiome, immunotherapy, immuno-oncology, metabolic diseases, and other related therapeutic research and consulting services to pharmaceuticals, biotechnology firms, CRO partners, and small to mid-size research and discovery organizations.
We can offer support for your research activities through various in-vivo and in-vitro assays. We can help you understand the action mechanisms of your therapeutics while also helping optimize the way you test your drug candidate for patent application, pre-clinical, and clinical work.
With a combined 40+ years of experience along with developing and optimizing hundreds of assay protocols, we can cover every aspect of your research needs. Our team of experts is always up-to-date within preclinical and clinical domains. We commit ourselves to enhancing the science behind your technology and to increasing your productivity.
Assay development with validation and precision
Strong Customer Relationship
Dedication and Integrity
Analytical approaches and advanced thinking
Drug development is progressing rapidly
Meet our new director of cellular Imaging— Dr. Patrizia Marchese
Dr. Patrizia Marchese gained her degree magna cum laude in Biological Science at the University of Genova, Italy.
After her doctoral degree, she joined The Scripps Research Institute in the Molecular and Experimental Medicine as a Postdoctoral Fellow, specializing in Thrombosis and Haemostasis research focused on function of platelets and their interaction with the vessel wall.
As Staff Scientist at The Scripps Research Institute, she gained expertise in techniques ranging from real time confocal and epifluorescent microscopy, flow studies on relevant thrombotic surfaces, in-vivo microsurgery and in-vivo video microscopy with the aim of studying mechanisms underlying physiologic hemostasis and pathological thrombosis.
After 27 years at The Scripps Research Institute, she now works as an independent scientific consultant and has set up a state-of-the-art fluorescent microscopy facility in her company, ThromboScience.
